Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies17
- 7D-0.01%
- 3M-7.1%
- 1Y11.5%
- YTD3.5%
The Life Sciences is pretty flat in the last 7 days, but WDB coco has stood out, gaining 4.6%. The past year has been better, since the industry has gained 18% in that time. Earnings are forecast to be flat in the coming years.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | JP¥297.3b | JP¥172.1b | JP¥14.2b | 16x | 21x | 1.7x |
| Sun, 01 Jan 2023 | JP¥297.8b | JP¥166.1b | JP¥16.2b | 15.3x | 18.4x | 1.8x |
| Tue, 29 Nov 2022 | JP¥332.5b | JP¥165.5b | JP¥16.0b | 15.6x | 20.8x | 2x |
| Thu, 27 Oct 2022 | JP¥320.5b | JP¥160.1b | JP¥12.4b | 16.2x | 25.9x | 2x |
| Sat, 24 Sep 2022 | JP¥314.6b | JP¥160.1b | JP¥12.4b | 18.4x | 25.4x | 2x |
| Mon, 22 Aug 2022 | JP¥311.1b | JP¥159.7b | JP¥12.3b | 18.8x | 25.4x | 1.9x |
| Wed, 20 Jul 2022 | JP¥293.1b | JP¥152.8b | JP¥10.9b | 18.3x | 26.9x | 1.9x |
| Fri, 17 Jun 2022 | JP¥269.0b | JP¥152.8b | JP¥10.9b | 17.2x | 24.7x | 1.8x |
| Sun, 15 May 2022 | JP¥232.8b | JP¥152.7b | JP¥11.3b | 19.9x | 20.5x | 1.5x |
| Tue, 12 Apr 2022 | JP¥247.1b | JP¥144.9b | JP¥10.6b | 21x | 23.3x | 1.7x |
| Thu, 10 Mar 2022 | JP¥228.5b | JP¥144.7b | JP¥10.6b | 17.6x | 21.6x | 1.6x |
| Sat, 05 Feb 2022 | JP¥260.1b | JP¥143.4b | JP¥9.7b | 22.8x | 26.8x | 1.8x |
| Mon, 03 Jan 2022 | JP¥284.1b | JP¥136.0b | JP¥6.8b | 23.8x | 42.1x | 2.1x |
| Wed, 01 Dec 2021 | JP¥329.5b | JP¥135.7b | JP¥6.9b | n/a | 47.8x | 2.4x |
| Fri, 29 Oct 2021 | JP¥396.4b | JP¥198.8b | JP¥8.1b | 25.9x | 49.1x | 2x |
| Sun, 26 Sep 2021 | JP¥381.6b | JP¥198.7b | JP¥8.1b | 25.9x | 47.3x | 1.9x |
| Tue, 24 Aug 2021 | JP¥351.1b | JP¥201.8b | JP¥5.0b | 23.9x | 69.6x | 1.7x |
| Wed, 30 Jun 2021 | JP¥375.1b | JP¥201.8b | JP¥5.0b | 26.2x | 74.4x | 1.9x |
| Sat, 03 Apr 2021 | JP¥301.1b | JP¥193.8b | JP¥2.3b | 24.6x | 128.3x | 1.6x |
| Tue, 05 Jan 2021 | JP¥273.7b | JP¥191.5b | JP¥116.2m | 26.7x | 2355.1x | 1.4x |
| Fri, 09 Oct 2020 | JP¥321.2b | JP¥189.9b | -JP¥496,535,000.00 | 55.3x | -647x | 1.7x |
| Thu, 02 Jul 2020 | JP¥327.4b | JP¥189.7b | JP¥2.0b | 19.4x | 162x | 1.7x |
| Sun, 05 Apr 2020 | JP¥202.5b | JP¥193.4b | JP¥2.7b | 18.1x | 74x | 1x |
Price to Earnings Ratio
132x
Current Industry PE
- Investors are pessimistic on the Japanese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 18.4x which is lower than its 3-year average PE of 170x.
- The industry is trading close to its 3-year average PS ratio of 1.7x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 103% per year over the last three years.
- Meanwhile revenues for these companies have declined 4.4% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.51% | |
| Healthcare | -3.11% | |
| Life Sciences | -0.013% | |
| Clinical Research and Equipment | -0.013% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥2.50k | 9.6% +JP¥9.1b | 51.0% | PE16.7x | |
| 2397 DNA Chip Research | JP¥844.00 | 8.9% +JP¥402.2m | 101.9% | PS13.1x | |
| 7079 WDB coco | JP¥5.90k | 0.2% +JP¥23.9m | 2.8% | PE21.7x | |
| 6190 PhoenixBio | JP¥706.00 | 0.6% +JP¥13.8m | 43.2% | PE24.6x |